Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 49

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 49
---
 which this prospectus is a part of has been independently verified or confirmed. Moreover, the price
of the Units being offered in the Offering was arbitrarily determined by us, and said price has no relation to our business, assets or
any other indica.

As a best efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we believe is required for our business plans.

We are attempting to raise an aggregate of $5,000,000
without the assistance of any underwriter, placement agent or any other third party. There is no required minimum number of units that
must be sold as a condition to completion of this offering. Because there is no minimum offering amount required as a condition to the
closing of this offering, the actual offering amount is not presently determinable and may be substantially less than the maximum amount
we are attempting to raise. We may sell fewer than all of the units offered hereby, which may significantly reduce the amount of proceeds
received by us, and investors in this offering will not receive a refund in the event that we do not sell any minimum amount of units.
Thus, we may not raise the amount of capital we believe is required for our operations in the short-term and may need to raise additional
funds, which may not be available or available on terms acceptable to us.

Because the Company is offering to sell Units Comprised of two shares of our Common Stock and one warrant for an additional share of Common Stock at an expected public offering price $3.20 per Unit and, afterour Common Stock is quoted on the OTCQX or the OTCQB marketplace of OTC Market or our Common Stock are listed on a national securities exchange, the Selling Shareholders will be offering to sell shares at the then-prevailing market price, purchasers of shares from the Selling Shareholders could pay more or less per share than investors in the primary offering, resulting in potential depreciation in the value of the shares purchased by investors in the primary offering, and/or significant volatility in the trading price of our shares.

The per Unit public offering price to be sold
by the Company is expected to be $3.20 per Unit. The per share public price of the shares to be sold by the Selling Shareholders following
the quotation of our Common Stock on the OTCQX or the OTCQB marketplace of OTC Market or until the shares of our Common Stock are listed
on a national securities exchange will be at the then-prevailing market price.